13 results
HIV-Associated Neurocognitive Disorder (HAND)

Definition:
HIV-Associated Neurocognitive disorders categories:
• Asymptomatic neurocognitive impairment
• Mild neurocognitive impairment
• HIV dementia

Pathophysiology:
HIV frequently
frequently compromises ... • Depressive symptoms ... Clinical Presentation ... : The clinical ... individual variation, frequent
CNS Infection in HIV / AIDS - Differential Diagnosis Framework

Principles of HIV-Associated CNS Opportunistic Infections:
 •
CNS Infection in HIV ... Principles of HIV-Associated ... should be based on clinical ... with IRIS - Frequently ... Infections in HIV
IDSA Recommendations for Treating Isospora belli Infection in HIV-AIDS
Treating Isospora belli Infection
General Management Considerations:
 • Fluid
belli Infection in HIV-AIDS ... 800 mg) PO (or IV ... 3–4 weeks) if symptoms ... opportunistic #infections #HIVAIDS ... #pharmacology
Intern Pocket Cards - Antibiogram and Susceptibilities
VRE - MRSA - GRAM POSITIVES - GRAM NEGATIVES -
(IV or PO?) ... If on IV, can I ... (Use clinical data ... indicated) and if frequency ... antibiotics #management #pharmacology
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
Trypanosomiasis) in HIV-AIDS ... Preventing Clinical ... and preventing clinical ... opportunistic #infections #HIVAIDS ... #pharmacology
Multiple Sclerosis - Summary

Multiple Sclerosis (MS) is an autoimmune-mediated neurodegenerative disease of the central nervous system
Ataxia • GU: Frequent ... Signs and symptoms ... patients with clinically ... stimulation Clinical ... • Acute: - IV
Nontuberculous Mycobacteria (NTM) Infections 

Mycobacterial species other than those belonging to the Mycobacterium tuberculosis complex and
mucogenicum • HIV ... Advanced HIV (CD4 ... gastrointestinal symptoms ... loss occur less frequently ... (Symptoms, Imaging
IDSA Recommendations for Treating Coccidiodomycosis in HIV-AIDS
Treating Mild Infections (Such As Focal Pneumonia or asymptomatic patients
Coccidiodomycosis in HIV-AIDS ... 0.7–1.0 mg/kg IV ... • Use until clinical ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Preventing and Treating Cryptococcosis in HIV-AIDS
Treatment for cryptococcosis consists of 3 phases: induction,
Cryptococcosis in HIV-AIDS ... 0.7–1.0 mg/kg IV ... as substantial clinical ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Preventing and Treating Histoplasma Capsulatum Infections in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
Infections in HIV-AIDS ... amphotericin B at 3 mg/kg IV ... weeks or until clinically ... opportunistic #infections #HIVAIDS ... #pharmacology